{"title":"急性可逆性共济-肌阵挛性脑病与氟卡因胺治疗。","authors":"J Ghika, J J Goy, C Naegeli, F Regli","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>A 73 year-old patient with Wolff-Parkinson-White syndrome and paroxysmic supraventricular tachycardia developed an acute reversible encephalopathy within 15 days of initiation of flecainide. The clinical picture was characterized by visual hallucinations, agitation, anxiety, but no disorientation, and a severe cerebello-myoclonic syndrome with total inability to stand up and walk, which was fully reversible on discontinuing the medication.</p>","PeriodicalId":30134,"journal":{"name":"Swiss Archives of Neurology and Psychiatry","volume":"145 1","pages":"4-6"},"PeriodicalIF":0.0000,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Acute reversible ataxo-myoclonic encephalopathy with flecainide therapy.\",\"authors\":\"J Ghika, J J Goy, C Naegeli, F Regli\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A 73 year-old patient with Wolff-Parkinson-White syndrome and paroxysmic supraventricular tachycardia developed an acute reversible encephalopathy within 15 days of initiation of flecainide. The clinical picture was characterized by visual hallucinations, agitation, anxiety, but no disorientation, and a severe cerebello-myoclonic syndrome with total inability to stand up and walk, which was fully reversible on discontinuing the medication.</p>\",\"PeriodicalId\":30134,\"journal\":{\"name\":\"Swiss Archives of Neurology and Psychiatry\",\"volume\":\"145 1\",\"pages\":\"4-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1994-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Swiss Archives of Neurology and Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Swiss Archives of Neurology and Psychiatry","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Acute reversible ataxo-myoclonic encephalopathy with flecainide therapy.
A 73 year-old patient with Wolff-Parkinson-White syndrome and paroxysmic supraventricular tachycardia developed an acute reversible encephalopathy within 15 days of initiation of flecainide. The clinical picture was characterized by visual hallucinations, agitation, anxiety, but no disorientation, and a severe cerebello-myoclonic syndrome with total inability to stand up and walk, which was fully reversible on discontinuing the medication.
期刊介绍:
Schweizer Archiv für Neurologie und Psychiatrie Archives suisses de neu-rologie et de psychiatrie Swiss Archives of Neurology and Psychiatry Official publication of the Swiss Neurological Society and official scientific publication of the Swiss Society of Psychiatry and Psychotherapy and the Swiss Society for Child and Adolescent Psychiatry and Psychotherapy